» Articles » PMID: 6608049

Relationship of DUMP and Free FdUMP Pools to Inhibition of Thymidylate Synthase by 5-fluorouracil

Overview
Journal Mol Pharmacol
Date 1984 Mar 1
PMID 6608049
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to compare the pools of free FdUMP derived from 5-fluorouracil (FUra) and of dUMP synthesized de novo in Hep-2 and S-180 cells, their relationship to inhibition of thymidylate synthase (dTMP synthase; EC 2.1.1.45), and the effect of excess folinic acid (CF) on these parameters. These cells differ 50-fold in their sensitivity to FUra and, in the absence of thymidine, dTMP synthase is the growth-limiting site of action of FUra in S-180 cells, but in Hep-2 cells this site becomes growth-limiting only in the presence of excess folates. In both cells after a 3-hr incubation with varied concentrations of FUra, FdUMP comprised only 0.1-0.2% of the total acid-soluble pools derived from FUra. The changes in dUMP and FdUMP pools paralleled each other, dUMP being 1000-2000 times higher than FdUMP. The pools of dUMP increased only when dTMP synthase was significantly inhibited. This occurred in S-180 cells above 3 microM FUra and in Hep-2 cells above 30 microM, where the residual dTMP synthase was similar in both cells. Under these conditions, the dUMP and FdUMP pools in Hep-2 cells were 2 and 4 times higher, respectively, than in S-180 cells. After FUra removal, both pools continued to increase, dUMP and FdUMP pools in Hep-2 cells rising 6-fold and 10-fold higher, respectively, than in S-180 cells. The dTMP synthase inhibition and the high nucleotide pools in Hep-2 were short-lived, whereas in S-180 cells the inhibition and the pools were maintained longer. Excess CF retarded the recovery of dTMP synthase after FUra removal only in Hep-2 cells and led to a further increase in dUMP and FdUMP pools in these cells, while having no effect in S-180 cells. These data indicate that a high capacity of cells to accumulate free FdUMP does not alone guarantee that dTMP synthase inhibition will be growth-limiting. The relationship shown here between excess CF, dTMP synthase recovery, and the nucleotide pools suggests that some cell types, such as Hep-2, in spite of high levels of FdUMP, require in addition an excess of folates to retard dTMP synthase recovery and make it growth-limiting.

Citing Articles

Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.

Sadahiro S, Suzuki T, Tanaka A, Okada K, Saito G, Miyakita H Cancer Chemother Pharmacol. 2017; 79(6):1077-1085.

PMID: 28417167 PMC: 5438825. DOI: 10.1007/s00280-017-3295-8.


Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study.

Zhao H, Chen G, Huang Y, Li X, Feng J, Shi M Medicine (Baltimore). 2015; 94(2):e249.

PMID: 25590835 PMC: 4602552. DOI: 10.1097/MD.0000000000000249.


Evolution of metamorphism in thymidylate synthases within the primate lineages.

Luo B, Johnson S, Lebioda L, Berger S J Mol Evol. 2011; 72(3):306-14.

PMID: 21318388 DOI: 10.1007/s00239-011-9433-8.


Uracil in DNA: consequences for carcinogenesis and chemotherapy.

Berger S, Pittman D, Wyatt M Biochem Pharmacol. 2008; 76(6):697-706.

PMID: 18599024 PMC: 2562027. DOI: 10.1016/j.bcp.2008.05.019.


A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.

Whitehead R, Benedetti J, Abbruzzese J, Ardalan B, Williamson S, Gaynor E Invest New Drugs. 2004; 22(4):467-73.

PMID: 15292717 DOI: 10.1023/B:DRUG.0000036689.28596.c6.